These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24919267)

  • 21. Expression of vascular endothelial growth factor (VEGF-A) in rat mandibular salivary gland during paraneoplastic process and treatment with cyclophosphamide and melatonin.
    Ovsyanko EV; Kulishenko AO; Lushnikova EL; Vinogradov AS; Zhurakovskii IP; Pustovetova MG; Ovsyanko YU
    Bull Exp Biol Med; 2015 Mar; 158(5):676-80. PubMed ID: 25778658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological evaluation of the radioprotective effects of melatonin against X-ray-induced early and acute testis damage in Albino rats: an animal model.
    Hussein MR; Abu-Dief EE; Abou El-Ghait AT; Adly MA; Abdelraheem MH
    Int J Exp Pathol; 2006 Jun; 87(3):237-50. PubMed ID: 16709232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
    Kooistra KL; Rodriguez M; Powis G
    Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of melatonin on the growth of pituitary prolactin-secreting tumor in rats.
    Yang QH; Xu JN; Xu RK; Pang SF
    J Pineal Res; 2006 Apr; 40(3):230-5. PubMed ID: 16499559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of antitumor activity of antibodies to TNF-α on Walker carcinosarcoma model.
    Yurlova EI; Krylova SG; Dugina JL; Epstein OI
    Bull Exp Biol Med; 2013 Sep; 155(5):673-5. PubMed ID: 24288736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the solid Walker-carcinosarcoma 256 in the rat during administration of cytostatics].
    Mattern J; Volm M; Wayss K
    Arzneimittelforschung; 1972 Oct; 22(10):1721-2. PubMed ID: 4677063
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of heparin complexed with urea on tumor growth and the ultrastructure of malignant cells].
    Kudriashov BA; Kolomina SM; Kalishevskaia TM; Pogodina LS; Chentsov IuS
    Farmakol Toksikol; 1979; 42(2):147-55. PubMed ID: 437082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats.
    Kamocka M; Kaplinska K; Mielicki WP
    Clin Exp Med; 2006 Oct; 6(3):119-23. PubMed ID: 17061060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of vasopressin gene expression on the growth of Walker 256 carcinosarcoma in rats].
    Khegaĭ II; Popova NA; Ivanova LN
    Genetika; 2006 Jul; 42(7):993-5. PubMed ID: 16915932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bax/Bcl-2 protein expression ratio and leukocyte function are related to reduction of Walker-256 tumor growth after β-hydroxy-β-methylbutyrate (HMB) administration in Wistar rats.
    Kuczera D; Paro de Oliveira HH; Fonseca Guimarães Fde S; de Lima C; Alves L; Machado AF; Coelho I; Yamaguchi A; Donatti L; Naliwaiko K; Fernandes LC; Nunes EA
    Nutr Cancer; 2012; 64(2):286-93. PubMed ID: 22242972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quantitative study of changes in the cellular composition of the spleen during growth of Walker carcinosarcoma].
    Volodarskaia TA; Erokhin VN
    Izv Akad Nauk SSSR Biol; 1978; (4):624-9. PubMed ID: 681597
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of immunosuppressants on the subrenal capsule (SRC) assay as a chemosensitivity test].
    Irimajiri N; Haneda J; Yokoyama E; Shirakabe M; Matsumoto M; Kusunoki T; Utsunomiya J
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):449-55. PubMed ID: 3348631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of guinea-pig serum on the Walker 256 carcinosarcoma.
    Dolowy WC; Schrek R; Henson D; Cornet J; Brown E
    Nature; 1968 Jun; 218(5146):1028-31. PubMed ID: 5656616
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of autotransfusion of photo-modified blood on the growth of Walker's carcinosarcoma].
    Chalenko VV; Zhilkina SV; Rakovshchik DG; Medvedev AN
    Vopr Onkol; 1991; 37(7-8):830-4. PubMed ID: 1842637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Energy controllable steep pulse (ECSP) treatment suppresses tumor growth in rats implanted with Walker 256 carcinosarcoma cells through apoptosis and an antitumor immune response.
    Luo XD; Sun JC; Liu F; Hu LN; Dong XJ; Sun DN; Xiao J
    Oncol Res; 2012; 20(1):31-7. PubMed ID: 23035363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kinetics of regression and relapse of Walker carcinosarcoma treated with alkylating agents].
    Parkanskiĭ MN; Konovalova NP; Emanuél' N
    Izv Akad Nauk SSSR Biol; 1973; (1):144-6. PubMed ID: 4218850
    [No Abstract]   [Full Text] [Related]  

  • 37. Sequence of events in experimental metastases of Walker 256 tumor: light, immunofluorescent, and electron microscopic observations.
    Jones DS; Wallace AC; Fraser EE
    J Natl Cancer Inst; 1971 Mar; 46(3):493-504. PubMed ID: 4100699
    [No Abstract]   [Full Text] [Related]  

  • 38. Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology.
    Gonzalez A; del Castillo-Vaquero A; Miro-Moran A; Tapia JA; Salido GM
    J Pineal Res; 2011 Apr; 50(3):250-60. PubMed ID: 21118301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of feeding response to cold exposure of rats bearing Walker 256 carcinosarcoma.
    Morrison SD
    Cancer Res; 1982 Feb; 42(2):490-5. PubMed ID: 6948607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA polymerases of Walker 256 carcinosarcoma.
    Waalkes TP; Sanders K; Smith RG; Adamson RH
    Cancer Res; 1974 Feb; 34(2):385-91. PubMed ID: 4129818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.